Mehrdad Jafari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mehrdad Jafari has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
Ebrahim Karimi
Otolaryngology Research Center, Amiralam Hospital, Tehran University of Medical Sciences, Tehran, Iran
4 shared publicationsAmin Amali
Assistant Professor, Department of Otolaryngology-Head and Neck Surgery, Otolaryngology Research Center, Imam Khomeini Medical Complex, Tehran University of Medical Sciences, Tehran, Iran
3 shared publicationsAkbar Bayat
Otorhinolaryngology Research Center, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications- Ali Bagheri Hagh
New Hearing Technologies Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
2 shared publications - Amir Arvin Sazegar
Otorhinolaryngology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
2 shared publications Fatemeh Tavakolnejad
Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications
Latest Publications
- 31 October 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
Risk thresholds for selective neck management in cN0 lower lip SCC: a decision-analytic prediction model
Management of the clinically node-negative (cN0) neck in lower lip squamous cell carcinoma (LLSCC) remains controversial because the risk of occult metastasis must be balanced against the morbidity of elective neck dissection (END). We aimed to identify predictors of early cervical nodal failure under an observation-first strategy and to translate them into a threshold-based decision-support framework. In this multicenter retrospective cohort, 208 consecutive LLSCC patients were screened, and 74 cN0 patients treated with primary tumor resection without upfront END were included. The primary endpoint was early cervical nodal failure within 12 months, defined as failure of surveillance. A full postoperative multivariable model including DOI, tumor size, and closest histopathologic margin was fitted for individualized postoperative risk estimation. A simplified DOI-size risk stratification scheme was constructed for clinically intuitive group-level interpretation and threshold-based decision support. Discrimination, calibration with bootstrap validation and shrinkage, ROC-derived thresholds, and decision curve analysis were performed. The simplified DOI-size strata were interpreted against a prespecified 20% elective-treatment threshold, with sensitivity analyses at 15% and 25%. Early nodal failure occurred in 15 of 74 patients (20.3%). DOI (OR 1.95 per mm, 95% CI 1.19 to 3.21, P = .008) and tumor size (OR 3.06 per cm, 95% CI 1.30 to 7.18, P = .010) independently predicted failure, whereas closest histopathologic margin showed an inverse but non-significant association (OR 0.74 per mm, 95% CI 0.52 to 1.06, P = .102). The full DOI-size-margin model achieved an apparent AUC of 0.85 with acceptable calibration after optimism correction, with a shrinkage slope of 0.86 and calibration-in-the-large of 0.03. ROC-derived thresholds were DOI ≥ 7 mm and tumor size ≥ 3 cm, while DOI ≥ 6 mm was retained as a conservative clinical boundary for simplified bedside stratification. The simplified DOI-size stratification separated 12-month nodal failure risk into 0.0% in the low-risk group (0/12), 12.2% in the intermediate-risk group (5/41), and 47.6% in the high-risk group (10/21). Only the high-risk group exceeded the prespecified 20% decision boundary. Decision curve analysis demonstrated superior net benefit of the full postoperative model compared with the reduced DOI-size model and treat-all or treat-none strategies across clinically relevant thresholds. In cN0 LLSCC managed without upfront END, a full postoperative prediction model incorporating DOI, tumor size, and closest histopathologic margin provides individualized estimation of early surveillance failure risk. DOI and tumor size remain the dominant clinically interpretable variables for simplified bedside risk stratification, while closest histopathologic margin contributes postoperative risk refinement in the full model. When embedded within a threshold-based framework, this combined approach supports selective rather than routine elective neck management. External validation is warranted.
- 31 October 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
Risk thresholds for selective neck management in cN0 lower lip SCC: a decision-analytic prediction model
Management of the clinically node-negative (cN0) neck in lower lip squamous cell carcinoma (LLSCC) remains controversial because the risk of occult metastasis must be balanced against the morbidity of elective neck dissection (END). We aimed to identify predictors of early cervical nodal failure under an observation-first strategy and to translate them into a threshold-based decision-support framework. In this multicenter retrospective cohort, 208 consecutive LLSCC patients were screened, and 74 cN0 patients treated with primary tumor resection without upfront END were included. The primary endpoint was early cervical nodal failure within 12 months, defined as failure of surveillance. A full postoperative multivariable model including DOI, tumor size, and closest histopathologic margin was fitted for individualized postoperative risk estimation. A simplified DOI-size risk stratification scheme was constructed for clinically intuitive group-level interpretation and threshold-based decision support. Discrimination, calibration with bootstrap validation and shrinkage, ROC-derived thresholds, and decision curve analysis were performed. The simplified DOI-size strata were interpreted against a prespecified 20% elective-treatment threshold, with sensitivity analyses at 15% and 25%. Early nodal failure occurred in 15 of 74 patients (20.3%). DOI (OR 1.95 per mm, 95% CI 1.19 to 3.21, P = .008) and tumor size (OR 3.06 per cm, 95% CI 1.30 to 7.18, P = .010) independently predicted failure, whereas closest histopathologic margin showed an inverse but non-significant association (OR 0.74 per mm, 95% CI 0.52 to 1.06, P = .102). The full DOI-size-margin model achieved an apparent AUC of 0.85 with acceptable calibration after optimism correction, with a shrinkage slope of 0.86 and calibration-in-the-large of 0.03. ROC-derived thresholds were DOI ≥ 7 mm and tumor size ≥ 3 cm, while DOI ≥ 6 mm was retained as a conservative clinical boundary for simplified bedside stratification. The simplified DOI-size stratification separated 12-month nodal failure risk into 0.0% in the low-risk group (0/12), 12.2% in the intermediate-risk group (5/41), and 47.6% in the high-risk group (10/21). Only the high-risk group exceeded the prespecified 20% decision boundary. Decision curve analysis demonstrated superior net benefit of the full postoperative model compared with the reduced DOI-size model and treat-all or treat-none strategies across clinically relevant thresholds. In cN0 LLSCC managed without upfront END, a full postoperative prediction model incorporating DOI, tumor size, and closest histopathologic margin provides individualized estimation of early surveillance failure risk. DOI and tumor size remain the dominant clinically interpretable variables for simplified bedside risk stratification, while closest histopathologic margin contributes postoperative risk refinement in the full model. When embedded within a threshold-based framework, this combined approach supports selective rather than routine elective neck management. External validation is warranted.
- Open Access
- 26 July 2022
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2022 (7) , omac075
Subglottic mucormycosis in a COVID-19 patient: a rare case report
Mucormycosis is an opportunistic fungal infection caused by fungi of Mucorale order. Uncontrolled diabetes mellitus and other immunosuppressive conditions such as neutropenia and corticosteroid therapy are known risk factors. A new risk factor for this infection is COVID-19 which facilitates mucormycosis by different mechanisms. The rhino-orbito-cerebral involvement is the most common form. Involvement of other anatomical regions may occur in rare situations. As we presented here, a 51-year-old woman presented with respiratory distress and subglottic lesion during COVID-19 (Delta variant) treatment which was diagnosed by histopathological examination as a subglottic mucormycosis postoperatively. The patient underwent tracheostomy and debridement of the necrotic tissues followed by antifungal treatment. New manifestations of COVID-19 are appearing over time. The association between coronavirus and mucormycosis of the laryngeal and airway region must be given serious consideration. Current guidelines recommend a combined medical and surgical approach for achieving the best outcome.
- 26 July 2022
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2022 (7) , omac075
Open AccessSubglottic mucormycosis in a COVID-19 patient: a rare case report
Mucormycosis is an opportunistic fungal infection caused by fungi of Mucorale order. Uncontrolled diabetes mellitus and other immunosuppressive conditions such as neutropenia and corticosteroid therapy are known risk factors. A new risk factor for this infection is COVID-19 which facilitates mucormycosis by different mechanisms. The rhino-orbito-cerebral involvement is the most common form. Involvement of other anatomical regions may occur in rare situations. As we presented here, a 51-year-old woman presented with respiratory distress and subglottic lesion during COVID-19 (Delta variant) treatment which was diagnosed by histopathological examination as a subglottic mucormycosis postoperatively. The patient underwent tracheostomy and debridement of the necrotic tissues followed by antifungal treatment. New manifestations of COVID-19 are appearing over time. The association between coronavirus and mucormycosis of the laryngeal and airway region must be given serious consideration. Current guidelines recommend a combined medical and surgical approach for achieving the best outcome.
- 28 April 2022
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 75 (7) , 2387-2440
Rhinoplasty in adult patients with isolated ala nasi cleft
- 28 April 2022
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 75 (7) , 2387-2440
Rhinoplasty in adult patients with isolated ala nasi cleft
- 1 April 2022
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 60 (3) , 286-290
Novel modification of infrahyoid myocutaneous flap for the reconstruction of oral cavity defects
- 1 April 2022
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 60 (3) , 286-290
Novel modification of infrahyoid myocutaneous flap for the reconstruction of oral cavity defects
- Open Access
- 23 February 2022
- Published by Knowledge E DMCC in ACTA MEDICA IRANICA
Comparison of Partial Laryngectomy Versus Radiotherapy for the Treatment of Early Glottic Carcinoma: Complications and Oncological Results: A Nonrandomized Clinical Trial
The aim of this non-randomized clinical trial was to evaluate tumor outcomes and subjective quality of voice following radiotherapy and partial laryngectomy in early-stage glottic laryngeal cancers. Non-Randomized Clinical Trial. Otolaryngology and radiation oncology clinics of Imam Khomeini (an affiliated hospital of Tehran University of Medical Sciences) and Amir Aalam Hospitals. Fifteen patients with early-stage glottic laryngeal carcinoma were admitted to the otolaryngology clinic, divided into two treatment groups: radiotherapy and partial laryngectomy. Of the total 50 patients, 25 had a partial laryngectomy and 25 radiotherapies. The comparison of the average of the Voice Handicap Index (VHI) showed significant improvement of vocal quality after treatment for both partial laryngectomy and radiotherapy (P<0.0001 for both). But there was no significant difference in VHI mean scores between the two treatment groups (patients treated by partial laryngectomy and radiotherapy). Short- and long-term complication was higher in patients undergoing surgery than radiotherapy group (P<0.0001). With regard to oncological outcome after one and eight-year after treatment, no differences were observed in the two treatment groups; there was a significant relationship between smoking cessation and recurrence of disease in the partial laryngectomy treatment group (P=0.012). There was no significant difference in voice quality and life expectancy of patients operated on using open surgery and patients treated with radiotherapy in this series. Open surgery may have more noticeable complications than radiotherapy.
- 23 February 2022
- Published by Knowledge E DMCC in ACTA MEDICA IRANICA
Open AccessComparison of Partial Laryngectomy Versus Radiotherapy for the Treatment of Early Glottic Carcinoma: Complications and Oncological Results: A Nonrandomized Clinical Trial
The aim of this non-randomized clinical trial was to evaluate tumor outcomes and subjective quality of voice following radiotherapy and partial laryngectomy in early-stage glottic laryngeal cancers. Non-Randomized Clinical Trial. Otolaryngology and radiation oncology clinics of Imam Khomeini (an affiliated hospital of Tehran University of Medical Sciences) and Amir Aalam Hospitals. Fifteen patients with early-stage glottic laryngeal carcinoma were admitted to the otolaryngology clinic, divided into two treatment groups: radiotherapy and partial laryngectomy. Of the total 50 patients, 25 had a partial laryngectomy and 25 radiotherapies. The comparison of the average of the Voice Handicap Index (VHI) showed significant improvement of vocal quality after treatment for both partial laryngectomy and radiotherapy (P<0.0001 for both). But there was no significant difference in VHI mean scores between the two treatment groups (patients treated by partial laryngectomy and radiotherapy). Short- and long-term complication was higher in patients undergoing surgery than radiotherapy group (P<0.0001). With regard to oncological outcome after one and eight-year after treatment, no differences were observed in the two treatment groups; there was a significant relationship between smoking cessation and recurrence of disease in the partial laryngectomy treatment group (P=0.012). There was no significant difference in voice quality and life expectancy of patients operated on using open surgery and patients treated with radiotherapy in this series. Open surgery may have more noticeable complications than radiotherapy.
- Open Access
- 4 June 2021
- Published by Hindawi Limited in Case Reports in Neurological Medicine
- Vol. 2021, 1-3
Protracted COVID-19 during Treatment of Facial Palsy
Neurologic manifestations are increasingly reported as the coronavirus disease 2019 (COVID-19) pandemic continues. This is a report of a COVID-19 patient with Bell's palsy. Case Summary. A 52-year-old man with fever and malaise was tested positive for COVID-19. After a week, he developed right-sided peripheral facial palsy and was treated with corticosteroids in conjunction with antiviral treatment which resulted in complete recovery. Discussion. Concomitant treatment of corticosteroids and antiviral treatment can decrease morbidity in patients with COVID-19-related Bell's palsy.
- 4 June 2021
- Published by Hindawi Limited in Case Reports in Neurological Medicine
- Vol. 2021, 1-3
Open AccessProtracted COVID-19 during Treatment of Facial Palsy
Neurologic manifestations are increasingly reported as the coronavirus disease 2019 (COVID-19) pandemic continues. This is a report of a COVID-19 patient with Bell's palsy. Case Summary. A 52-year-old man with fever and malaise was tested positive for COVID-19. After a week, he developed right-sided peripheral facial palsy and was treated with corticosteroids in conjunction with antiviral treatment which resulted in complete recovery. Discussion. Concomitant treatment of corticosteroids and antiviral treatment can decrease morbidity in patients with COVID-19-related Bell's palsy.
- 9 May 2021
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 74 (1) , 85-89
Incus Autograft Partial Ossicular Reconstruction Prosthesis vs. Titanium Angular Clip Prosthesis in Patients with Incudostapedial Joint Erosion Caused by Chronic Otitis Media; A Randomized Clinical Trial
Chronic otitis media (COM) is a common disease that can cause damage to the middle ear ossicles and thus lead to conductive hearing loss. The purpose of this study was to compare two methods of incus partial ossicular reconstruction prosthesis (PORP) and reconstruction with titanium angular clip prosthesis in patients with incudostapedial joint erosion. In this interventional randomized clinical trial carried out in a tertiary referral hospital, patients with chronic otitis media and incudostapedial joint erosion who were candidates for surgery, were randomly allocated into two groups of incus PORP surgery and reconstruction with a titanium angular clip prosthesis. Audiometry was performed for the patients prior to and six months after surgery. Pre- and post-operative air–bone gap (ABG) and bone conduction (BC) thresholds were calculated and means were compared by analysis of variances (ANOVA). A P value of <0.05 was considered statistically significant. The study consisted of 24 and 14 subjects in the incus PORP and angular clip groups, respectively. There was no statistically significant difference between the mean pre- and post-operative ABG, BC thresholds and ABG reduction in the compared groups. Considering issues such as high cost and inaccessibility of titanium angular clips in all centers, incus PORP may be a more acceptable method.
- 9 May 2021
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 74 (1) , 85-89
Incus Autograft Partial Ossicular Reconstruction Prosthesis vs. Titanium Angular Clip Prosthesis in Patients with Incudostapedial Joint Erosion Caused by Chronic Otitis Media; A Randomized Clinical Trial
Chronic otitis media (COM) is a common disease that can cause damage to the middle ear ossicles and thus lead to conductive hearing loss. The purpose of this study was to compare two methods of incus partial ossicular reconstruction prosthesis (PORP) and reconstruction with titanium angular clip prosthesis in patients with incudostapedial joint erosion. In this interventional randomized clinical trial carried out in a tertiary referral hospital, patients with chronic otitis media and incudostapedial joint erosion who were candidates for surgery, were randomly allocated into two groups of incus PORP surgery and reconstruction with a titanium angular clip prosthesis. Audiometry was performed for the patients prior to and six months after surgery. Pre- and post-operative air–bone gap (ABG) and bone conduction (BC) thresholds were calculated and means were compared by analysis of variances (ANOVA). A P value of <0.05 was considered statistically significant. The study consisted of 24 and 14 subjects in the incus PORP and angular clip groups, respectively. There was no statistically significant difference between the mean pre- and post-operative ABG, BC thresholds and ABG reduction in the compared groups. Considering issues such as high cost and inaccessibility of titanium angular clips in all centers, incus PORP may be a more acceptable method.
- Open Access
- 1 January 2021
- Published by Wiley in Dermatology Research and Practice
- Vol. 2021 (1)
Clinical Diagnosis has a High Negative Predictive Value in Evaluation of Malignant Skin Lesions
Background. The increasing incidence of skin cancers in fair‐skinned population and its relatively good response to treatment make its accurate diagnosis of great importance. We evaluated the accuracy of clinical diagnosis of malignant skin lesions by comparing the clinical diagnosis with histological diagnosis as the gold standard. Materials and Methods. In this retrospective study, we assessed all the pathology reports from specimens sent to a university hospital laboratory in 3 consecutive years from March 2008 to March 2010. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and positive and negative likelihood ratios were calculated for clinical diagnosis of malignant skin lesions stratified by their histological subtype. Results. A total 4,123 specimen were evaluated. The sensitivity and specificity for clinical diagnosis of malignancy were 90.48% and 82.85%, respectively, whereas the negative predictive value was shown to be 99.06%. The positive and negative likelihood ratios were 5.23 and 0.11, respectively. Conclusion. Pathological assessment of skin lesions remains the cornerstone of skin cancer diagnosis. The high NPV and the relatively low PPV indicate that clinical diagnosis is more efficient in ruling out malignancies rather than diagnosing them.
- 1 January 2021
- Published by Wiley in Dermatology Research and Practice
- Vol. 2021 (1)
Open AccessClinical Diagnosis has a High Negative Predictive Value in Evaluation of Malignant Skin Lesions
Background. The increasing incidence of skin cancers in fair‐skinned population and its relatively good response to treatment make its accurate diagnosis of great importance. We evaluated the accuracy of clinical diagnosis of malignant skin lesions by comparing the clinical diagnosis with histological diagnosis as the gold standard. Materials and Methods. In this retrospective study, we assessed all the pathology reports from specimens sent to a university hospital laboratory in 3 consecutive years from March 2008 to March 2010. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and positive and negative likelihood ratios were calculated for clinical diagnosis of malignant skin lesions stratified by their histological subtype. Results. A total 4,123 specimen were evaluated. The sensitivity and specificity for clinical diagnosis of malignancy were 90.48% and 82.85%, respectively, whereas the negative predictive value was shown to be 99.06%. The positive and negative likelihood ratios were 5.23 and 0.11, respectively. Conclusion. Pathological assessment of skin lesions remains the cornerstone of skin cancer diagnosis. The high NPV and the relatively low PPV indicate that clinical diagnosis is more efficient in ruling out malignancies rather than diagnosing them.
- Open Access
- 10 November 2020
- Published by Springer Nature in BMC Oral Health
- Vol. 20 (1) , 1-8
Serum and salivary levels of lactate dehydrogenase in oral squamous cell carcinoma, oral lichen planus and oral lichenoid reaction
Background: Increased levels of lactate dehydrogenase (LDH) as a tumor marker have been reported in malignant and some premalignant oral lesions such as oral lichen planus (OLP) and oral lichenoid reactions (OLRs). This study aimed to assess the level of total LDH in the saliva and serum of patients with oral squamous cell carcinoma (OSCC), OLP and OLRs.Methods: In this case–control study, the participants were divided into four groups (n = 25) of healthy controls, OLP, OLRs, and OSCC. The serum and stimulated/unstimulated salivary levels of LDH were spectrophotometrically measured using standard LDH kits (Pars Azmoun). One-way ANOVA, Chi-square test, Pearson’s correlation test, and receiver operating characteristic (ROC) analysis were applied to analyze the data.Results: The serum and salivary levels of LDH in OSCC patients were significantly higher than that the corresponding values in other groups (P = 0.0001). The serum level of LDH in OLR group was significantly higher than that in the control and OLP groups (P = 0.0001), but the difference in salivary level of LDH was not significant. The ROC analysis showed that both the serum and salivary levels of LDH had significant diagnostic ability for detection of OSCC and OLRs. Significant associations were noted between the serum and salivary levels of LDH.Conclusions: Patients with OSCC and OLRs had higher serum levels of LDH than OLP and control groups. Further prospective longitudinal studies are required to assess the tissue level of LDH and monitor the transformation of OLRs because they have low rate of malignant transformation compared with other oral premalignant lesions.
- 10 November 2020
- Published by Springer Nature in BMC Oral Health
- Vol. 20 (1) , 1-8
Open AccessSerum and salivary levels of lactate dehydrogenase in oral squamous cell carcinoma, oral lichen planus and oral lichenoid reaction
Background: Increased levels of lactate dehydrogenase (LDH) as a tumor marker have been reported in malignant and some premalignant oral lesions such as oral lichen planus (OLP) and oral lichenoid reactions (OLRs). This study aimed to assess the level of total LDH in the saliva and serum of patients with oral squamous cell carcinoma (OSCC), OLP and OLRs.Methods: In this case–control study, the participants were divided into four groups (n = 25) of healthy controls, OLP, OLRs, and OSCC. The serum and stimulated/unstimulated salivary levels of LDH were spectrophotometrically measured using standard LDH kits (Pars Azmoun). One-way ANOVA, Chi-square test, Pearson’s correlation test, and receiver operating characteristic (ROC) analysis were applied to analyze the data.Results: The serum and salivary levels of LDH in OSCC patients were significantly higher than that the corresponding values in other groups (P = 0.0001). The serum level of LDH in OLR group was significantly higher than that in the control and OLP groups (P = 0.0001), but the difference in salivary level of LDH was not significant. The ROC analysis showed that both the serum and salivary levels of LDH had significant diagnostic ability for detection of OSCC and OLRs. Significant associations were noted between the serum and salivary levels of LDH.Conclusions: Patients with OSCC and OLRs had higher serum levels of LDH than OLP and control groups. Further prospective longitudinal studies are required to assess the tissue level of LDH and monitor the transformation of OLRs because they have low rate of malignant transformation compared with other oral premalignant lesions.
- Open Access
Treatment of Head and Neck Venous Malformations with Sodium Tetradecyl Sulfate
Objective: The purpose of this study was to discuss the clinical outcomes and complications of treating venous malformations with sclerotherapy, with sodium tetradecyl sulfate as the sclerosing agent.Study Design: Case series with planned data collection.Setting: Amiralam Hospital—a referral otolaryngology–head and neck surgery hospital affiliated with Tehran University of Medical Sciences.Subjects and Methods: A total of 345 patients with venous malformations were treated with sclerotherapy with sodium tetradecyl sulfate 3% (1 mL for every 1 cm3 of the lesion). The venous malformation location, treatments before the current sclerotherapy with sodium tetradecyl sulfate, the number of sclerotherapy sessions, and complications resulting from sclerotherapy were recorded. Follow‐up assessments were done for a minimum of 1 year following the procedure. A favorable outcome was defined as a 50% decrease in the lesion size based on clinical and radiologic assessments.Results: A total of 759 injection sessions were documented, ranging from 1 to 6 injections per patient (mean = 3.1). The follow‐up duration ranged from 12 to 84 months (mean = 55 months). Based on clinical assessment, a 50% reduction of size was reported for 95.6% of the patients. According to the imaging before and after the procedures, a 50% reduction of size was seen among 67.3% of the patients.Conclusion: The results of the study showed that the use of sodium tetradecyl sulfate as a sclerosing substance can effectively reduce the size of venous malformation lesions.
Open AccessTreatment of Head and Neck Venous Malformations with Sodium Tetradecyl Sulfate
Objective: The purpose of this study was to discuss the clinical outcomes and complications of treating venous malformations with sclerotherapy, with sodium tetradecyl sulfate as the sclerosing agent.Study Design: Case series with planned data collection.Setting: Amiralam Hospital—a referral otolaryngology–head and neck surgery hospital affiliated with Tehran University of Medical Sciences.Subjects and Methods: A total of 345 patients with venous malformations were treated with sclerotherapy with sodium tetradecyl sulfate 3% (1 mL for every 1 cm3 of the lesion). The venous malformation location, treatments before the current sclerotherapy with sodium tetradecyl sulfate, the number of sclerotherapy sessions, and complications resulting from sclerotherapy were recorded. Follow‐up assessments were done for a minimum of 1 year following the procedure. A favorable outcome was defined as a 50% decrease in the lesion size based on clinical and radiologic assessments.Results: A total of 759 injection sessions were documented, ranging from 1 to 6 injections per patient (mean = 3.1). The follow‐up duration ranged from 12 to 84 months (mean = 55 months). Based on clinical assessment, a 50% reduction of size was reported for 95.6% of the patients. According to the imaging before and after the procedures, a 50% reduction of size was seen among 67.3% of the patients.Conclusion: The results of the study showed that the use of sodium tetradecyl sulfate as a sclerosing substance can effectively reduce the size of venous malformation lesions.